Ceribell Expands Board of Directors with Appointments of Thomas West and Sharon O’Keefe

SUNNYVALE, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced the appointments of Thomas “Tom” West and Sharon O’Keefe to its Board of Directors. The new directors bring commercial and health-system leadership experience to the Board as the company expands adoption of its point-of-care brain monitoring platform, now deployed in more than 680 U.S. hospitals.

“We are thrilled to welcome Tom and Sharon to our Board,” said Rebecca “Beckie” Robertson, chair of the Ceribell Board of Directors. “Tom has spent his career scaling medical technologies from clinical validation to broad commercial adoption and market leadership, and Sharon has led some of the country’s largest academic health systems. Their highly complementary experience will be invaluable as Ceribell works to cement its category leadership through innovation and provide greater access to point-of-care brain monitoring.”